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I was first introduced 10 the interaction between 
diabetes and coronary artery disease when I was a 
medical student sitting in the diabetes clinic run by my 
father, Professor Joseph de Bono, at St. Luke's Hospital. 
My group has retained an interest in diabetes, and in 
particular type 11 or non-insulin dependent diabetes, in 
relation to coronary artery disease because of its 
particular relevance to heart disease in our immigrant 
Indo Asian community in Leicester, UK. 
From the cardiologist's viewpoint, we know that 
diabetes increases the rate of development of coronary 
atheroma, increases the risk of a coronary thrombosis, 
and has a deleterious effect on the outcome of 
myocardial infarction. For simplicity, I shall concentrate 
on ways in which diabetes may accelerate atheroma. 
Everyone accepts that both type I (primary insulin 
deficiency) and type II (insulin resistance + relative 
insulin deficiency) diabetes are associated with an 
increased risk of coronary atheroma, but there is 
controversy over the number of different mechanisms 
involved. 
In type I diabetes , there is increasing evidence that 
hyperglycaemia itself plays an important part, although 
contributions from dyslipidaemia and from immune 
reactions to older non-human insulin cannot be excluded. 
There is good reason to believe that meticulous diabetic 
control, together with attention to conventional coronary 
risk factors will prevent, or at least reduce the risk of 
developing microvascular or macrovascular disease. 
The question of type II diabetes, which is a more 
important community cause of coronary disease because 
of its higher prevalence, is more difficult: not least 
because clinical non-insulin dependent diabetes is only 
the tip of an iceberg whose lower parts are formed from 
increasingly large populations with asymptomatic 
hyperglycaemia, glucose intolerance and insulin 
resistance. 
"The insulin resistance syndrome" is a convenient 
short-hand for an association of central obesity, high 
fasting serum insulin concentrations, high plasma insulin 
concentrations following a glucose load or during 
glucose clamp studies. and a predisposition to 
hypertension and coronary heart disease. Also part of 
the syndrome is a trend towards high plasma triglyceride 
concentrations, a high concentration of "small dense" 
LDL particles, and a high plasminogen activator 
inhibitor type 1 (PAI-I) concentrations 1-3. The 
fundamental cause of the syndrome is unknown. 
Without doubt, it can be exacerbated by overnutrition 
and physical inactivity, and conversely ameliorated by 
exercise and fasting 4.5. Insulin-sensitive muscle glucose 
uptake has been shown to be abnormal in young relatives 
of' patients with non-insulin dependent diabetes; 
exercise dramatically increases insulin sensitivity, but 
does not restore it to normal 6. Several other studies 
have shown a strong correlation between physical 
inactivity and insulin resistance, on both an individual 
and a population basis. This raises, however. an 
interesting question as to whether it is physical inactivity 
which causes insulin resistance. or whether some 
fundamental defect in muscle glucose metabolism in 
itself predisposes to physical inactivity. The possibility 
that at least the susceptibility to insulin resistance is 
genetically determined, and/or influenced by foetal or 
neonatal nutrition, cannot be excluded and tS currently 
the subject of active investigation. 
Although the 	 majority of patients with insulin 
resistance are 'normoglycaemic' by conventional 
standards, we 	 cannot exclude the possibility that 
prolonged exposure to even very moderate 
hyperglycaemia can cause arterial damage. 
Glycosylated haemoglobin levels have been shown to bc 
elevated in young non-diabetic relatives of patients with 
type 11 diabetes. A hypothesis which has been even 
more vigorously pursued has been the concept that 
insulin itself can be atherogenic 7. In a variety of in­
vitro models 	 insulin can be shown to ll1crease 
plasminogen activator inhibitor production by liver cells , 
and to alter the 	behaviour of smooth muscle cells from 
the vessel wall 	H,'1 . Whether these effects are enough, 
over a period of time , to cause atherosclerotic changes in 
the vessel wall, is unproven. Finally. an excess of 
insulin in the presence of normal or high concentrations 
of glucose. can lead to the excessive production of low 
density and very low density lipoprotein and hence to 
dyslipidaemia . 	 Even if we do not know the precise 
causative mechanisms, there is now overwhelming 
epidemiological 	and clinical evidence that the metabolic 
environment of 	insulin resistance strongly encourages 
the development of coronary atheroma. 
From our own work and that of others , insulin 
resistance emerges as a powerful independent predictor 
of coronary artery disease risk, and the magnitude of its 
effect is similar to that of differences in plasma 
. cholesterol concentration. There is a strong correlation 
between the plasma insulin concentrations of patients 
with coronary disease, and those of their apparently 
unaffected children 10. In the children of coronary 
disease patients we also found a strong negative 
correlation between plasma insulin concentrations and 
physical exercise 11. 
What are the implications of insulin resistance for the 
prevention and management of coronary artery disease 
in diabetics') Perhaps the most depressing implication is 
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that by the time patients have developed clinically 
apparent non-insulin dependent diabe tes, they almost 
certainly have also developed coronary artery disease 
whether or not this is clinically manifest at the same 
time . It is therefore very important in the initial 
management advice given to such patients that vigorous 
efforts are made to reduce other risk factors (smoking, 
high blood pressure, high cholesterol) which would 
contribute to the progression of coronary atheroma. The 
traditional emphasis on glycaemic control in these 
patients, though it may prevent the onset of severe 
hyperglycaemia and may, perhaps, have an impact on 
microvascular complications almost certainly has little 
rele vance to the progression of coronary disease. For 
this to be prevented, or at least slowed, it is essential that 
insulin resistance is reversed, by increased physical 
activity and, where appropriate, by weight loss . It is 
interesting that, whereas most diabetic clinics are 
meticulous about maintaining records of patient weight, 
very few record physical activity in any standardised 
way, or use objective measures such as pedometers . 
Since we now recognise that type I and type II diabe tes 
have different aetiologies, there is no reason why the two 
phenotypes should not co-exist in the same patient, and 
in populations with a high prevalence of insulin 
res is tance this is indeed likely to occur. Patients who are 
often particularly difficult to manage are those who 
present with a combination of angina , obesity and insulin 
resistance. They tend to become locked into a vicious 
circle where angina prevents physical activity and 
inactivity results in increased obesity and insulin 
resistance. An aggressive approach to coronary 
revascularisation may be appropriate, but it needs to be 
emphasised to the patient that this will only be effective 
if he or she is prepared to make the effort to adopt a 
different lifes tyle. An important implication of recent 
evidence on the inheritance of insulin resistance is that it 
is not only possible, but indeed essential. to look for the 
condi tion in asymptomatic young relati ves of affected 
pati ents at an age whe re lifestyle modification is easier, 
and where it has a real chance of preventing the later 
development of coronary artery di sease. 
In summary . it can be a mistake to regard type IT or 
non-insulin dependent diabe tes as a 'mild' condition . 
Particularl y in the presence of other cardiovascular risk 
factors . it can cause a major population burden of 
cardiovascular disease. Anticipation and prevention is 
important: waiting for the condition to become clinically 
manifest may seriously jeopardise long term outcoI1le. 
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